Hydrate Heroes for Improving Brain Function & Mood
ConditionHydration Status
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of South Florida
About this trial
The primary goal of this 12-week randomized controlled study is to evaluate whether daily use of Hydrate Heroes results in measurable improvements in brain activity, mental health, and performance on cognitive tasks. By analyzing brainwave data, physical response metrics, and patient-reported outcomes, the study will demonstrate whether the supplement produces meaningful effects on mental and neurological health.
Eligibility criteria
Qualifiers
Age between 18 and 65 years at time of consent.
Fluent in English (able to read, write, speak, and understand English).
Generally healthy, without chronic medical conditions (see Exclusion 10.3).
Willing and able to attend three in-person study visits over an approximate 12-week period (enrollment, ~6 weeks, ~12 weeks).
Disqualifiers
Neurological or Psychiatric Conditions
History of epilepsy, recurrent seizures, severe head injury, or other significant neurological disorders.
Current diagnosis of major psychiatric disorders (e.g., schizophrenia, bipolar disorder, severe major depressive disorder).
Chronic kidney disease, congestive heart failure, or any condition requiring medically supervised fluid restriction.
Trial design
Treatments tested in this trial
- Hydrate Heroes (6 packets)
- Hydrate Heroes (3 packets)
Treatment groups
48 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov